{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:33:41Z","timestamp":1789054421208,"version":"build-2803163510"},"reference-count":110,"publisher":"Wiley","issue":"s422","license":[{"start":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T00:00:00Z","timestamp":1093564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p><jats:bold>Objective:\u2002<\/jats:bold> To assess new treatment options for bipolar disorders.<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> Controlled studies of new treatments for bipolar disorders were identified by computerized searches and reviews of scientific meeting proceedings, and were compiled by drug category.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Two main categories of medications, newer anticonvulsants and newer antipsychotics, are yielding emerging new treatment options for bipolar disorders. Newer anticonvulsants have diverse psychotropic profiles, and although not generally effective for acute mania, may have utility for other aspects of bipolar disorders (e.g. lamotrigine for maintenance or acute bipolar depression), or for comorbid conditions (e.g. gabapentin for anxiety or pain, topiramate for obesity, bulimia, alcohol dependence, or migraine, and zonisamide for obesity). In contrast, newer antipsychotics generally appear effective for acute mania, and some may ultimately prove effective in acute depression (e.g. olanzapine combined with fluoxetine, quetiapine) and maintenance (e.g. olanzapine).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Emerging research is yielding new treatment options for bipolar disorders and comorbid conditions.<\/jats:p>","DOI":"10.1111\/j.1600-0447.2004.00410.x","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T09:32:37Z","timestamp":1093599157000},"page":"18-33","source":"Crossref","is-referenced-by-count":18,"title":["New medication treatment options for bipolar disorders"],"prefix":"10.1111","volume":"110","author":[{"given":"T. A.","family":"Ketter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nowakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. K.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,8,27]]},"reference":[{"key":"e_1_2_23_2_2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","article-title":"Lithium salts in the treatment of psychotic excitement","volume":"14","author":"Cade JFJ.","year":"1949","journal-title":"Med J Aust"},{"key":"e_1_2_23_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"e_1_2_23_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"e_1_2_23_5_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0717"},{"key":"e_1_2_23_6_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1011"},{"key":"e_1_2_23_7_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1210"},{"key":"e_1_2_23_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.1.62"},{"key":"e_1_2_23_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1146"},{"key":"e_1_2_23_10_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.2.141"},{"key":"e_1_2_23_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200210000-00011"},{"key":"e_1_2_23_12_2","unstructured":"MullenJ DevineN SweitzerD.Quetiapine adjunctive therapy for acute mania associated with bipolar disorder(SIAM). In:156th Annual Meeting of the American Psychiatric Association2003: San Francisco CA May 17\u201322. Abstract NR482 pp.108\u2013pp. 101."},{"key":"e_1_2_23_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200004000-00012"},{"key":"e_1_2_23_14_2","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","year":"2002","journal-title":"Am J Psychiatry"},{"key":"e_1_2_23_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"e_1_2_23_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300190"},{"key":"e_1_2_23_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00434-7"},{"key":"e_1_2_23_18_2","unstructured":"SachsG AltshulerL KetterT SuppesT RasgonN FryeM CollinsM.Divalproex versus placebo for the treatment of bipolar depression. In:40th Annual Meeting of the American College of Neuropsychopharmacology2001: Waikaloa Hawaii December 9\u201313 Abstract p.232."},{"key":"e_1_2_23_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311043291904"},{"key":"e_1_2_23_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000125745.60149.c6"},{"key":"e_1_2_23_21_2","unstructured":"AltshulerLL RasgonNL SaadM ElmanS NolenWA BitranJA FryeMA.Reproductive endocrine function in women treated for bipolar disorder. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR740 p.278."},{"key":"e_1_2_23_22_2","unstructured":"JoffeH CohenLS SuppesT McLaughlinWL AdamsJM MolayFJ et\u00a0al.Polycystic ovarian syndrome is associated with valproate use in bipolar women. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR264 p.98."},{"key":"e_1_2_23_23_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0405"},{"key":"e_1_2_23_24_2","unstructured":"WeislerRH KeckPE Jr. SwannAC.Treatment of manic and mixed patients with carbamazepine extended release. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR360 p.133."},{"key":"e_1_2_23_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199106000-00009"},{"key":"e_1_2_23_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199110000-00006"},{"key":"e_1_2_23_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02916252"},{"key":"e_1_2_23_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00007"},{"key":"e_1_2_23_29_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0511"},{"key":"e_1_2_23_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/10401230309085675"},{"key":"e_1_2_23_31_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.20305.x"},{"key":"e_1_2_23_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200012000-00004"},{"key":"e_1_2_23_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199908000-00010"},{"key":"e_1_2_23_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200008000-00011"},{"key":"e_1_2_23_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(02)00255-5"},{"key":"e_1_2_23_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000100121.58594.11"},{"key":"e_1_2_23_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1837"},{"key":"e_1_2_23_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00008"},{"key":"e_1_2_23_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"e_1_2_23_40_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0906"},{"key":"e_1_2_23_41_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0203"},{"key":"e_1_2_23_42_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n1106"},{"key":"e_1_2_23_43_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0210"},{"key":"e_1_2_23_44_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1110"},{"key":"e_1_2_23_45_2","unstructured":"WangPW ChandlerRA AlarconAM NowakowskaC MarshWK KetterTA.Low incidence of lamotrigine treatment\u2010emergent rash with dermatology precautions. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR348 p.129."},{"key":"e_1_2_23_46_2","unstructured":"PowersP SachsGS KushnerSF WangD OlsonW CapeceJ FazzioL RosenthalN.Topiramate in adults with acute bipolar I mania: pooled results. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR365 p.135."},{"key":"e_1_2_23_47_2","unstructured":"DelBelloMP KushnerSF WangD OlsonW CapeceJ FazzioL RosenthalN.Topiramate for acute mania in adolescent patients with bipolar I disorder. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR363 pp.134\u2013135."},{"key":"e_1_2_23_48_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1109"},{"key":"e_1_2_23_49_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.255"},{"key":"e_1_2_23_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2003.102"},{"key":"e_1_2_23_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13370-3"},{"key":"e_1_2_23_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.8.965"},{"key":"e_1_2_23_53_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.01189.x"},{"key":"e_1_2_23_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01123.x"},{"key":"e_1_2_23_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00407-4"},{"key":"e_1_2_23_56_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1107"},{"key":"e_1_2_23_57_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.01201.x"},{"key":"e_1_2_23_58_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1016"},{"key":"e_1_2_23_59_2","unstructured":"RothT WalshJK.Sleep\u2010consolidating effects of tiagabine in patients with primary insomnia. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR839 pp.315\u2013pp. 316."},{"issue":"1","key":"e_1_2_23_60_2","first-page":"83","article-title":"Studies with (Trileptal) oxcarbazepine in acute mania","volume":"5","author":"Emrich HM.","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"key":"e_1_2_23_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1993.tb04106.x"},{"key":"e_1_2_23_62_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.3.588"},{"key":"e_1_2_23_63_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.34699.x"},{"key":"e_1_2_23_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00779.x"},{"key":"e_1_2_23_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704766"},{"key":"e_1_2_23_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00185-X"},{"key":"e_1_2_23_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2003.09.004"},{"key":"e_1_2_23_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)01724-2"},{"key":"e_1_2_23_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01409-7"},{"key":"e_1_2_23_70_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.148"},{"key":"e_1_2_23_71_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017002015"},{"key":"e_1_2_23_72_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0707"},{"key":"e_1_2_23_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(01)00296-0"},{"key":"e_1_2_23_74_2","first-page":"13","article-title":"Interaction of zonisamide with benzodiazepine and GABA receptors in rat brain","volume":"39","author":"Mimaki T","year":"1990","journal-title":"Med J Osaka University"},{"key":"e_1_2_23_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701941"},{"key":"e_1_2_23_76_2","doi-asserted-by":"crossref","unstructured":"ChadwickDW MarsonAG.Zonisamide add\u2010on for drug\u2010resistant partial epilepsy. Cochrane Database Syst Rev2002(2) p. CD001416.","DOI":"10.1002\/14651858.CD001416"},{"key":"e_1_2_23_77_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.14.1820"},{"key":"e_1_2_23_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(94)90078-7"},{"key":"e_1_2_23_79_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700918"},{"key":"e_1_2_23_80_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0108"},{"key":"e_1_2_23_81_2","unstructured":"YangY NowakowskaC BeckerOV SchumacherM StrongCM WangP KetterTA.Weight loss during first two months of open adjunctive zonisamide for obesity in bipolar disorder patients. In:156th Annual Meeting of the American Psychiatric Association2003: San Francisco CA May 17\u201322 Abstract NR14 pp.5\u20136."},{"key":"e_1_2_23_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(03)00099-2"},{"key":"e_1_2_23_83_2","unstructured":"GoodwinFR JamisonK.Biochemical and pharmacological studies. In:Manic\u2010Depressive Illness1990: Oxford University Press: New York p.416\u2013502."},{"key":"e_1_2_23_84_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.1.82"},{"key":"e_1_2_23_85_2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","article-title":"Clinical outcome in a randomized 1\u2010year trial of clozapine versus treatment as usual for patients with treatment\u2010resistant illness and a history of mania","volume":"156","author":"Suppes T","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_23_86_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen M","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_23_87_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"e_1_2_23_88_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.12.1218"},{"key":"e_1_2_23_89_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.11.1079"},{"key":"e_1_2_23_90_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"e_1_2_23_91_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.4.337"},{"key":"e_1_2_23_92_2","unstructured":"TohenMF BowdenCL CalabreseJR SachsGS JacobsT BakerRW EvansAR.Olanzapine versus placebo for relapse prevention in bipolar disorder. In:156th Annual Meeting of the American Psychiatric Association2003: San Francisco CA May 17\u201322 Abstract NR197 p.73."},{"key":"e_1_2_23_93_2","unstructured":"TohenMF MarnerosA BowdenCL JacobsT BakerRW EvansAR CassanoGB.Olanzapine versus lithium in relapse prevention in bipolar disorder. In:156th Annual Meeting of the American Psychiatric Association2003: San Francisco CA May 17\u201322. Abstract NR509 pp.190\u2013pp. 191."},{"issue":"1","key":"e_1_2_23_94_2","first-page":":","article-title":"Open\u2010label maintenance treatment for bipolar depression using olanzapine or olanzapine\/fluoxetine combination","volume":"6","author":"Ketter TA","year":"2004","journal-title":"International Society for Bipolar Disorders Regional Group Conference"},{"key":"e_1_2_23_95_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.596"},{"key":"e_1_2_23_96_2","unstructured":"HirschfeldRMA KeckPE Jr. KarcherMS KramerML GrossmanF.Rapid antimanic effect of risperidone monotherapy: a three\u2010week multicenter randomized double\u2010blind placebo\u2010controlled trial. In:156th Annual Meeting of the American Psychiatric Association2003: San Francisco CA May 17\u201322. Abstract NR182 p.67."},{"key":"e_1_2_23_97_2","unstructured":"KhannaS HirschfeldRMA KarcherK GrossmanF KramerML.Risperidone monotherapy in acute bipolar mania. In:156th Annual Meeting of the American Psychiatric Association2003: San Francisco CA May 17\u201322. Abstract NR424 p.159."},{"key":"e_1_2_23_98_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1011"},{"key":"e_1_2_23_99_2","unstructured":"JonesMW HuizarK.Quetiapine monotherapy for acute mania associated with bipolar disorder (STAMP 1 and STAMP 2). In:156th Annual Meeting of the American Psychiatric Association2003: San Francisco CA May 17\u201322 Abstract NR432 p.162."},{"key":"e_1_2_23_100_2","unstructured":"PaulssonB JonesMW.Sustained remission\/euthymia with quetiapine monotherapy for bipolar mania. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR754 pp.283\u2013pp. 284."},{"key":"e_1_2_23_101_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200405000-00010"},{"key":"e_1_2_23_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00075-7"},{"key":"e_1_2_23_103_2","unstructured":"CalabreseJ MacfaddenW McCoyR MinkwitzM WilsonE MullenJ.Double\u2010blind placebo\u2010controlled study of quetiapine in bipolar depression. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136 Abstract NR756 p.284."},{"key":"e_1_2_23_104_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"e_1_2_23_105_2","unstructured":"PotkinSG SpragueR KeckPE Jr. GillerE Jr. IceK WarringtonL DunnJ.Ziprasidone in bipolar mania: efficacy across patient subgroups. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136 Abstract NR777 p.292."},{"key":"e_1_2_23_106_2","unstructured":"WeislerRH WarringtonL DunnJ EnglishP.Adjunctive ziprasidone in bipolar mania: short\u2010term and long\u2010term data. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR358 pp.132\u2013133."},{"key":"e_1_2_23_107_2","unstructured":"KeckPE Jr. PotkinSG GillerE Jr. IceK WarringtonL DunnJ.Ziprasidone's long\u2010term efficacy and safety in bipolar disorder. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR745 p.280."},{"key":"e_1_2_23_108_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"e_1_2_23_109_2","unstructured":"SachsGS SanchezR MarcusRN KujawaMJ ArchibaldDG CarsonWH Jr. IwamotoT.Aripiprazole versus placebo in patients with an acute manic or mixed episode. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR742 p.279."},{"key":"e_1_2_23_110_2","unstructured":"BourinM AubyP MarcusRN SwanikR McQuadeRD IwamotoT SanchezR.Aripiprazole versus haloperidol for maintained treatment effect in acute mania. In:156th Annual Meeting of the American Psychiatric Association2003: San Francisco CA May 17\u201322. Abstract NR467 p.175."},{"key":"e_1_2_23_111_2","unstructured":"KeckPE Jr. SanchezR MarcusRN CarsonWH Jr. RollinL Taro IwamotoT StockEG.Aripiprazole for relapse prevention in bipolar disorder in a 26\u2010week trial. In:157th Annual Meeting of the American Psychiatric Association2004: New York NY May 1\u20136. Abstract NR746 p.280."}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.2004.00410.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.2004.00410.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T16:16:40Z","timestamp":1695745000000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.2004.00410.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,27]]},"references-count":110,"journal-issue":{"issue":"s422","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.1600-0447.2004.00410.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.2004.00410.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,27]]}}}